Search Results Search Sort by RelevanceMost Recent State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Imatinib is a pharmaceutical therapy recently approved by the FDA to help treat chronic myeloid leukemia. Virtual Mentor. 2004; 6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411. Health Law Nov 2004 Wright v. Fred Hutchinson Cancer Center: Maintaining Patient and Public Trust in Clinical Research Laura Lin, MBA and Bryan A. Liang, MD, PhD, JD An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in. Virtual Mentor. 2004; 6(11):501-504. doi: 10.1001/virtualmentor.2004.6.11.hlaw1-0411. Medicine and Society Nov 2004 Gatekeeping and the FDA's Role in Human Subjects Protection Daniel Carpenter, PhD The FDA bears the responsibility to monitor clinical trials and protect human subjects from harm. Virtual Mentor. 2004; 6(11):512-514. doi: 10.1001/virtualmentor.2004.6.11.msoc1-0411. Policy Forum Nov 2004 Genetic Samples and Genetic Philanthropy Michael E. Berens, PhD and Gary E. Marchant, PhD, JD Genetic research is threatened by lack of samples, and public policy should be developed to encourage public participation. Virtual Mentor. 2004; 6(11):509-511. doi: 10.1001/virtualmentor.2004.6.11.pfor2-0411. In the Literature Nov 2004 Determining Research through Underdetermined Treatment Abraham P. Schwab, PhD Paul Miller and Charles Weijer defend the concept of equipoise in medical research in a recent journal article. Virtual Mentor. 2004; 6(11):488-489. doi: 10.1001/virtualmentor.2004.6.11.jdsc1-0411. State of the Art and Science Dec 2004 The Impact of Recent Clinical Trials on National Cholesterol Education Program Adult Treatment Panel III Guidelines Niharika P. Bansal Recent clinical trials have led to updates in the management of patients with high cholesterol. Virtual Mentor. 2004; 6(12):550-553. doi: 10.1001/virtualmentor.2004.6.12.cprl1-0412. History of Medicine Dec 2004 The Origins and Promise of Medical Standards Of Care Eleanor D. Kinney, JD, MPH Standards of care in medicine have gone through many changes and developments over the course of its history. Virtual Mentor. 2004; 6(12):574-576. doi: 10.1001/virtualmentor.2004.6.12.mhst1-0412. AMA Code Says Jul 2003 The Code on Physicians' Relationship with Industry Audiey C. Kao, MD, PhD The AMA's Code of Medical Ethics provides ample guidance for the interactions between pharmaceutical companies and physicians. Virtual Mentor. 2003; 5(7):263-264. doi: 10.1001/virtualmentor.2003.5.7.code1-0307. Case and Commentary Jul 2024 When Medication Treatment for Opioid Use Disorder Gets Disrupted by Extra-Clinical Variables, How Should Clinicians Respond? Taleed El-Sabawi, JD, PhD and Kelly Gillespie, JD, PhD, RN Clinicians caring for patients with OUD should plan for possible disruptions of treatment caused by arrests and pretrial confinements. AMA J Ethics. 2024; 26(7):E520-526. doi: 10.1001/amajethics.2024.520. Health Law Jul 2024 What Should the US Learn From New York’s and Portugal’s Approaches to the Opioid Crisis? Maura McGinnity Some US localities are trying interventions modeled on international approaches to decriminalization. AMA J Ethics. 2024; 26(7):E546-550. doi: 10.1001/amajethics.2024.546. Pagination First page « First Previous page ‹ Previous … Page 21 Page 22 Page 23 Page 24 Current page 25 Page 26 Page 27 Page 28 Page 29 … Next page Next › Last page Last »
State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Imatinib is a pharmaceutical therapy recently approved by the FDA to help treat chronic myeloid leukemia. Virtual Mentor. 2004; 6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411.
Health Law Nov 2004 Wright v. Fred Hutchinson Cancer Center: Maintaining Patient and Public Trust in Clinical Research Laura Lin, MBA and Bryan A. Liang, MD, PhD, JD An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in. Virtual Mentor. 2004; 6(11):501-504. doi: 10.1001/virtualmentor.2004.6.11.hlaw1-0411.
Medicine and Society Nov 2004 Gatekeeping and the FDA's Role in Human Subjects Protection Daniel Carpenter, PhD The FDA bears the responsibility to monitor clinical trials and protect human subjects from harm. Virtual Mentor. 2004; 6(11):512-514. doi: 10.1001/virtualmentor.2004.6.11.msoc1-0411.
Policy Forum Nov 2004 Genetic Samples and Genetic Philanthropy Michael E. Berens, PhD and Gary E. Marchant, PhD, JD Genetic research is threatened by lack of samples, and public policy should be developed to encourage public participation. Virtual Mentor. 2004; 6(11):509-511. doi: 10.1001/virtualmentor.2004.6.11.pfor2-0411.
In the Literature Nov 2004 Determining Research through Underdetermined Treatment Abraham P. Schwab, PhD Paul Miller and Charles Weijer defend the concept of equipoise in medical research in a recent journal article. Virtual Mentor. 2004; 6(11):488-489. doi: 10.1001/virtualmentor.2004.6.11.jdsc1-0411.
State of the Art and Science Dec 2004 The Impact of Recent Clinical Trials on National Cholesterol Education Program Adult Treatment Panel III Guidelines Niharika P. Bansal Recent clinical trials have led to updates in the management of patients with high cholesterol. Virtual Mentor. 2004; 6(12):550-553. doi: 10.1001/virtualmentor.2004.6.12.cprl1-0412.
History of Medicine Dec 2004 The Origins and Promise of Medical Standards Of Care Eleanor D. Kinney, JD, MPH Standards of care in medicine have gone through many changes and developments over the course of its history. Virtual Mentor. 2004; 6(12):574-576. doi: 10.1001/virtualmentor.2004.6.12.mhst1-0412.
AMA Code Says Jul 2003 The Code on Physicians' Relationship with Industry Audiey C. Kao, MD, PhD The AMA's Code of Medical Ethics provides ample guidance for the interactions between pharmaceutical companies and physicians. Virtual Mentor. 2003; 5(7):263-264. doi: 10.1001/virtualmentor.2003.5.7.code1-0307.
Case and Commentary Jul 2024 When Medication Treatment for Opioid Use Disorder Gets Disrupted by Extra-Clinical Variables, How Should Clinicians Respond? Taleed El-Sabawi, JD, PhD and Kelly Gillespie, JD, PhD, RN Clinicians caring for patients with OUD should plan for possible disruptions of treatment caused by arrests and pretrial confinements. AMA J Ethics. 2024; 26(7):E520-526. doi: 10.1001/amajethics.2024.520.
Health Law Jul 2024 What Should the US Learn From New York’s and Portugal’s Approaches to the Opioid Crisis? Maura McGinnity Some US localities are trying interventions modeled on international approaches to decriminalization. AMA J Ethics. 2024; 26(7):E546-550. doi: 10.1001/amajethics.2024.546.